rivaroxaban
janssen,BAYER
['prevent,hd', 'vte']
 reviews the 3 randomized trials presented this morning: , prevent-hd, and improve-dd risk assessment for vte, moving the needle on clinical care 
website url: https://t.co/SXRluuIpZq